Blog

Caring for Children's Mental Health
in a Time of Change

 

Across the country, programs that support children’s mental health are experiencing reductions in funding. While it is expected that funding cycles will rise and fall, the timing of these changes has created new challenges for many organizations committed to ensuring that young people have access to quality mental health care. In West Virginia, these grants have directly supported services, including school-based mental health programs and continuing clinician education. On April 29, 2025, it was announced that approximately $1 billion in federal funding for school-based mental health services, allocated initially through the Bipartisan Safer Communities Act, will end earlier than anticipated, concluding on December 31, 2025 (Odjaghian, 2025). The primary purpose of these funds was to provide expanded mental health support to students who are experiencing mental health challenges, which nearly 1 in 5 children, ages 3-17, struggle with and only about half receive treatment. In 2023, nearly 20% of high school students reported they considered suicide (Estrada, 2025).

Programs like these have been essential in rural and underserved regions such as Appalachia, where access to mental health care is often limited. As a 2024 poll from the American Psychiatric Association found, 84% of Americans agree that school staff play a crucial role in identifying early signs of mental health challenges among students (Turner, 2025). Additional programs that serve children are also facing disruptions. Head Start, which serves nearly 800,000 low-income children and families across the U.S., has been impacted by both funding delays and the closure of several federal offices that help administer the program, resulting in backlogs in grant processing (Cowan, 2025).

Other large-scale changes are also underway. Proposed reductions and restructuring to the Substance Abuse and Mental Health Services Administration (SAMHSA) and the Health Resources and Services Administration (HRSA) are expected to have broad effects on behavioral health services for children and families. SAMHSA supports community mental health programs, youth suicide prevention initiatives, and grants to expand the behavioral health workforce. Changes in staffing and grant structures may disrupt access to services such as the 988 Suicide & Crisis Lifeline (James, 2025). HRSA also has a long history of supporting provider education programs, such as the Rational Drug Therapy Program’s Academic Detailing Team, which may further strain an already limited pediatric mental health workforce, such as here in the Mountain State.

As these shifts in funding continue, many organizations are responding by scaling back services, reducing staff, or seeking new community partnerships to try to maintain adequate support for children and families. These cuts, whether proposed or implemented, will create challenges for organizations, schools, clinicians, and community programs that strive to meet the needs of our pediatric population. Our program is not immune to these changes. As a team that operates through a combination of state and federal grant funding, we, too, are facing the possibility of reduced capacity, or, depending on how the funding landscape evolves, the risk of discontinuation. This may mean that clinicians across the state will see us less in the coming months, not due to a lack of commitment, but rather due to a lack of resources. This fluid situation serves as a reminder to everyone in the healthcare ecosystem of the importance of a sustained effort and investment into services that support young people’s emotional well-being, especially during moments of transition. The investment in evidence-based programs enables us to improve access to care, support providers, and ultimately enhance the health outcomes of our patients. These models must not only be implemented but also be funded with a long-term vision in mind.

At the time of this writing, many of these changes are uncertain. Some of this funding may continue uninterrupted, while some of it may be discontinued; the only current certainty is great uncertainty. While we strive to ensure that everything we write is accurate, we ask that you understand that we are healthcare providers, not trained journalists. Our primary concern is for our patients, providers, and the people of West Virginia. As this landscape continues to evolve, the content of this blog may become rapidly outdated; we ask that you understand this. We hope that clinicians and organizations across the country will be able to continue their essential work of supporting the mental health needs of the next generation.

Author: West Virginia Rational Drug Therapy Program Academic Detailing Team

References:

General disclaimer:
This content is not intended to address all possible diagnosis methods, treatments, follow up, drugs or their related contraindications or side effects. Standards of practice change as new data becomes available. Therefore, it is strongly recommended that practitioners independently assess and verify diagnosis, treatments and drugs for each individual patient. The authors of the WV ACC guidelines assume no liability for any aspect of treatment administered by a practitioner with the aid of this publication.

Drug disclaimer:
The authors do not endorse or recommend the use of any particular drug mentioned in this publication. Before prescribing a new drug to a patient, practitioners are advised to check the product information accompanying each drug to ensure it is appropriate for a specific patient and to identify appropriate dosage, contraindications, side effects and drug-to-drug interactions.

Standard of care disclaimer:
This publication is not intended to establish a standard of care applicable to practitioners who treated patients diagnosed with ADHD. “Standard of care” is a legal term, not a medical term, which refers to the degree of care a reasonable practitioner would exercise under the same or similar circumstances. The standard of care is a continuum and does not imply optimal care. Practitioner discretion and clinical judgment are paramount and this publication is only intended to aid practitioners’ judgment, not to serve as a substitute for said judgment.